Liquidia shares crater after court rules for United Therapeutics

United Therapeutics stock is surging today following a court ruling that favored the company. In contrast, Liquidia shares have cratered as a direct result of this legal decision. The court's ruling has created a stark divergence in market performance between the two entities, driving a significant increase in value for United Therapeutics while causing a sharp decline for Liquidia. Investors are reacting to the judicial outcome which fundamentally impacts the standing of both pharmaceutical companies.